Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 9:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 793–816 of 1,488 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Standard Scheduling Clear all

Conditions: Patient Adherence, HIV
Interventions: SMS Text Message Reminder; Behavioral
Lead sponsor: Ann & Robert H Lurie Children's Hospital of Chicago; Other
Eligibility: 16 Years to 29 Years
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer
Interventions: Culdocentesis, Vaginal Swab, Chromopertubation, Blood collection, Tissue collection; Procedure
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older · Female only
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Castration-Resistant Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8
Interventions: Biospecimen Collection, Bone Scan, Clinical Observation, Computed Tomography, Gallium Ga 68 Gozetotide, Lutetium Lu 177 Vipivotide Tetraxetan, Positron Emission Tomography, Questionnaire Administration, Single Photon Emission Computed Tomography; Procedure · Other · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Male only
Enrollment: 236 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Autism Spectrum Disorders
Interventions: Patient Navigation; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 16 Months to 32 Months
Enrollment: 305 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 3
States / cities: Aurora, Colorado • Denver, Colorado

Conditions: Breast Neoplasms
Interventions: Contrast Enhanced Digital Mammography; Procedure
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 30 Years to 80 Years · Female only
Enrollment: 107 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Breast Cancer
Interventions: Breast surgery; Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 10
States / cities: Hartford, Connecticut • Ann Arbor, Michigan • Basking Ridge, New Jersey + 7 more

Conditions: Precancerous Condition
Interventions: Rituximab; Biological
Lead sponsor: Mayo Clinic; Other
Eligibility: 21 Years to 90 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2011
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Morbid Obesity
Interventions: Very low calorie diet; Dietary Supplement
Lead sponsor: Christiana Care Health Services; Other
Eligibility: 18 Years to 65 Years
Enrollment: 58 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Newark, Delaware

Conditions: Glioma, Malignant Glioma, Astrocytoma, Grade II, Oligodendroglioma, Glioma, Astrocytic, Oligoastrocytoma, Mixed
Interventions: IMA950, poly-ICLC, Varlilumab; Biological
Lead sponsor: Nicholas Butowski; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Sleep, Sleep Hygiene
Interventions: Timed evening technology and digital media use (tablet use), no technology and digital media use (screen media use); Behavioral
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 48 Months to 59 Months
Enrollment: 170 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Substance Abuse, HIV
Interventions: Tool to provide re-entry support and improve linkage to healthcare and social services; Behavioral
Lead sponsor: Temple University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Maternal Health
Interventions: Telehealth MOM, Enhanced Standard of Care; Behavioral · Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 1,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 6
States / cities: El Dorado, Arkansas • Fayetteville, Arkansas • Fort Smith, Arkansas + 3 more

Conditions: Latent Tuberculosis
Interventions: Regularly scheduled LTBI medication reminder text messages; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: High-Risk Prostate Cancer
Interventions: Capivasertib, abiraterone acetate; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 9
States / cities: West Los Angeles, California • Chicago, Illinois • St Louis, Missouri + 6 more

Conditions: Arthritis Foot, Trauma Injury, Deformity; Bone
Interventions: NanoBone Bone Graft Substitute; Other
Lead sponsor: Artoss Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 8
States / cities: Scottsdale, Arizona • Sarasota, Florida • Joliet, Illinois + 5 more

Conditions: Sleep-Disordered Breathing, Sleep Architecture
Interventions: Belun Ring, PSG; Device · Diagnostic Test
Lead sponsor: Belun Technology Company Limited; Other
Eligibility: 18 Years to 80 Years
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: COVID-19
Interventions: mHealth Outreach, Care Coordination; Other
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 398 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 4
States / cities: El Cajon, California • Escondido, California • La Jolla, California + 1 more

Conditions: Chronic Rhinosinusitis (Diagnosis)
Interventions: Ibuprofen 400 mg, Acetaminophen 650 mg, OxyCODONE 5 Mg Oral Tablet; Drug
Lead sponsor: University of Washington; Other
Eligibility: Not listed
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Incontinence, Urinary Stress, Prostate Cancer, Benign Prostate Hyperplasia
Interventions: Text message reminders; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older · Male only
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Lung Cancer, Head and Neck Cancer
Interventions: [F-18]FLT; Drug
Lead sponsor: Siemens Molecular Imaging; Industry
Eligibility: 18 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 2
States / cities: Newport Beach, California • Houston, Texas

Conditions: Chemotherapy-induced Nausea and Vomiting
Interventions: Aprepitant 125 mg, Fosaprepitant 115 MG, Dexamethasone, Ondansetron 16 MG; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 2
States / cities: The Bronx, New York

Conditions: Genital Neoplasm, Female
Interventions: Discharge instructions reminders, Prompts to report symptoms via the web-enabled app, Clinical Alerts; Behavioral
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older · Female only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 3
States / cities: Southaven, Mississippi • Memphis, Tennessee

Conditions: Basal Cell Carcinoma, Squamous Cell Carcinoma
Interventions: electronic brachytherapy; Radiation
Lead sponsor: Xoft, Inc.; Industry
Eligibility: 50 Years and older
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 5
States / cities: Tuscaloosa, Alabama • Casa Grande, Arizona • Scottsdale, Arizona + 2 more

Conditions: Erectile Dysfunction
Interventions: Penile Traction Device, Inflatable Penile Prosthesis Implantation; Device · Procedure
Lead sponsor: J. Peter Rubin, MD; Other
Eligibility: 18 Years and older · Male only
Enrollment: 48 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Text Messaging Intervention to Improve ART Adherence Among HIV-positive Youth

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Screening and Linkage to Services for Autism

Contrast Enhanced Mammography in Diagnosing Patients With Suspicious Breast Findings

Use of Sentinel Lymph Node Biopsy in Patients With Early-Stage, Palpable Node-Positive HR+/HER2- Breast Cancer Having Upfront Surgery and Adjuvant Radiation

Rituximab in Treating Patients With Peripheral Neuropathy Caused by Monoclonal Gammopathy of Undetermined Significance

Utilization of Very Low Calorie Diet in Obese General Surgery Patients

A Study of Varlilumab and IMA950 Vaccine Plus Poly-ICLC in Patients With WHO Grade II Low-Grade Glioma (LGG)

The Goodnight Screen Media Study

Testing a Mobile Health Application to Improve HIV Prevention and Substance Use Treatment Among Women Involved in the Carceral System

Telehealth Multi-Component Optional Model (MOM) Study

Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging

A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss

Artoss Foot and Ankle Surgery Registry

Belun Ring Platform With an Improved Algorithm for OSA Assessment

Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement

Effect of Post-operative Ibuprofen After Surgery for Chronic Rhinosinusitis

Effect of Text Message Reminders on M-ISI Score After Prostate Surgery

A Multi - Center Study Of PET Imaging With [F-18] FLT & [F-18] FDG in Cancer Patients for Treatment Evaluation

Low Dose Aprepitant for Patients Receiving Carboplatin

Post-Operative Gynecological Oncology App Study

Electronic Brachytherapy for the Treatment of NMSC

Penile Lengthening Pre-Penile Prosthesis Implantation